These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2944742)

  • 1. Human acid beta-glucosidase: affinity purification of the normal placental and Gaucher disease splenic enzymes on N-alkyl-deoxynojirimycin-sepharose.
    Osiecki-Newman KM; Fabbro D; Dinur T; Boas S; Gatt S; Legler G; Desnick RJ; Grabowski GA
    Enzyme; 1986; 35(3):147-53. PubMed ID: 2944742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human acid beta-glucosidase: use of inhibitors, alternative substrates and amphiphiles to investigate the properties of the normal and Gaucher disease active sites.
    Osiecki-Newman K; Fabbro D; Legler G; Desnick RJ; Grabowski GA
    Biochim Biophys Acta; 1987 Sep; 915(1):87-100. PubMed ID: 2956992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human acid beta-glucosidase: inhibition studies using glucose analogues and pH variation to characterize the normal and Gaucher disease glycon binding sites.
    Osiecki-Newman K; Legler G; Grace M; Dinur T; Gatt S; Desnick RJ; Grabowski GA
    Enzyme; 1988; 40(4):173-88. PubMed ID: 3234317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human lysosomal beta-glucosidase: purification by affinity chromatography.
    Grabowski GA; Dagan A
    Anal Biochem; 1984 Aug; 141(1):267-79. PubMed ID: 6437271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human acid beta-glucosidase. Use of conduritol B epoxide derivatives to investigate the catalytically active normal and Gaucher disease enzymes.
    Grabowski GA; Osiecki-Newman K; Dinur T; Fabbro D; Legler G; Gatt S; Desnick RJ
    J Biol Chem; 1986 Jun; 261(18):8263-9. PubMed ID: 3087971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analyses of catalytic activity and inhibitor binding of human acid beta-glucosidase by site-directed mutagenesis. Identification of residues critical to catalysis and evidence for causality of two Ashkenazi Jewish Gaucher disease type 1 mutations.
    Grace ME; Graves PN; Smith FI; Grabowski GA
    J Biol Chem; 1990 Apr; 265(12):6827-35. PubMed ID: 2324100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of activators and inhibitors to define the properties of the active site of normal and Gaucher disease lysosomal beta-glucosidase.
    Gatt S; Dinur T; Osiecki K; Desnick RJ; Grabowski GA
    Enzyme; 1985; 33(2):109-19. PubMed ID: 3924590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of a cytosolic beta-glucosidase from calf liver and characterization of its active site with alkyl glucosides and basic glycosyl derivatives.
    Legler G; Bieberich E
    Arch Biochem Biophys; 1988 Jan; 260(1):427-36. PubMed ID: 2963589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification by affinity chromatography of glucosidase I, an endoplasmic reticulum hydrolase involved in the processing of asparagine-linked oligosaccharides.
    Hettkamp H; Legler G; Bause E
    Eur J Biochem; 1984 Jul; 142(1):85-90. PubMed ID: 6235111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Separation by electrofocusing of the molecular forms of splenic beta-glucosidase in normal subjects and Gaucher's disease].
    Maret A; Salvayre R; Nègre A; Douste-Blazy L
    Biomedicine; 1980 May; 33(3):82-6. PubMed ID: 6778520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher's disease II. Studies on the kinetics of beta-glucosidase and the effects of sodium taurocholate in normal and Gaucher tissues.
    Choy FY; Davidson RG
    Pediatr Res; 1980 Jan; 14(1):54-9. PubMed ID: 6767218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-methyl-N-(5-carboxypentyl)-1-deoxynojirimycin, a new affinity ligand for the purification of trimming glucosidase I.
    Bause E; Gross A; Schweden J
    FEBS Lett; 1991 Jan; 278(2):167-70. PubMed ID: 1825064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational processing of human lysosomal acid beta-glucosidase: a continuum of defects in Gaucher disease type 1 and type 2 fibroblasts.
    Bergmann JE; Grabowski GA
    Am J Hum Genet; 1989 May; 44(5):741-50. PubMed ID: 2495719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophoretic separation of neutral and acid beta-glucosidase isozymes in human tissues.
    Shafit-Zagardo B; Devine EA; Desnick RJ
    Biochim Biophys Acta; 1980 Aug; 614(2):459-65. PubMed ID: 6773581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-glucosidase activity in liver, spleen and brain in acute neuropathic Gaucher disease.
    Takahashi T; Nishio H; Kodama S; Nakamura H
    Brain Dev; 1990; 12(2):202-5. PubMed ID: 2113779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The occurrence of two immunologically distinguishable beta-glucocerebrosidases in human spleen.
    Aerts JM; Donker-Koopman WE; van der Vliet MK; Jonsson LM; Ginns EI; Murray GJ; Barranger JA; Tager JM; Schram AW
    Eur J Biochem; 1985 Aug; 150(3):565-74. PubMed ID: 4018098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneity in human acid beta-glucosidase revealed by cellulose-acetate electrophoresis.
    Sa Miranda MC; Aerts JM; Pinto RA; Magalhaes JA; Barranger JA; Tager JM; Schram AW
    Biochim Biophys Acta; 1988 May; 965(2-3):163-8. PubMed ID: 3130106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A heterogeneous beta-D-glucosidase activator from monkey parotid gland and its use as an affinity ligand in the purification of human salivary beta-D-glucosidase.
    Nagarajan S; Cherian R; Balasubramanian AS
    Biochem Int; 1987 Feb; 14(2):365-73. PubMed ID: 3107568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro detergent activation of lysosomal acid beta-glucosidase in the spleen of normal and type 1 Gaucher patients is not accompanied by change in aggregation state.
    Maret A; Potier M; Salvayre R; Troly M; Beauregard G; Douste-Blazy L
    Biochim Biophys Acta; 1989 Jul; 996(3):254-6. PubMed ID: 2502183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical and kinetic properties of beta-glucosidase in Gaucher disease.
    Karazeh A; Carroll M
    J Inherit Metab Dis; 1983; 6(3):101-4. PubMed ID: 6422137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.